CN103285169A - Traditional Chinese medicine pill for treatment of chronic rhinitis - Google Patents

Traditional Chinese medicine pill for treatment of chronic rhinitis Download PDF

Info

Publication number
CN103285169A
CN103285169A CN2012100402814A CN201210040281A CN103285169A CN 103285169 A CN103285169 A CN 103285169A CN 2012100402814 A CN2012100402814 A CN 2012100402814A CN 201210040281 A CN201210040281 A CN 201210040281A CN 103285169 A CN103285169 A CN 103285169A
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
treatment
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012100402814A
Other languages
Chinese (zh)
Inventor
钟灿福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012100402814A priority Critical patent/CN103285169A/en
Publication of CN103285169A publication Critical patent/CN103285169A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine pill for treatment of chronic rhinitis. The traditional Chinese medicine pill comprises, by weight, the following traditional Chinese medicine ingredients: 8 to 10 parts of radix bupleuri, 8 to 10 parts of mint, 8 to 10 parts of chast tree berry, 8 to 10 parts of Chinese parsnip root, 8 to 10 parts of schizonepeta ear, 8 to 10 parts of baikal skullcap root, 8 to 10 parts of balloonflower root, 8 to 10 parts of ligusticum wallichii, 8 to 10 parts of dahurian angelica root, 8 to 10 parts of bitter organe, 80 to 100 parts of ox horn, 4 to 5 parts of Asarum Herb, 4 to 5 parts of gentian and 12 to 15 parts of lily magnolia. The ingredients of the invention are common pure traditional Chinese medicines, the compatibility of the ingredients is reasonable, and the ingredients are of no toxic and side effects. In applications, a combination of oral administration and external application of the traditional Chinese medicine pill is better for treatment.

Description

A kind of Chinese medicine pill for the treatment of chronic rhinitis
Technical field
The invention belongs to the Chinese medicine technical field of pharmaceuticals, especially a kind of Chinese medicine pill for the treatment of chronic rhinitis.
Background technology
Chronic rhinitis is the nonspecific inflammation of bronchia mucosal and Submucosa more than the lasting several months, or inflammation shows effect repeatedly, and Submucosa also can not recover normal person in the phase of gap.Clinical in persistence or intermittence, property nasal obstruction alternately, nasal mucus increases and is feature.Primary disease is many thoroughly not to be developed, develops and cause because of the acute rhinitis treatment.
Be divided into chronic simple rhinitis and chronic hypertrophic rhinitis clinically.Its clinical manifestation is:
Chronic simple rhinitis: nasal obstruction is intermittent or property alternately, generally by day, movable back nasal obstruction alleviates or disappear; Night, sat quietly for a long time, tired, meet that nasal obstruction increases the weight of when cold.When lying on one's side, the upside nasal airflow is good, the downside congestion.Nasal mucus mostly is mucus.The congested swelling of nasal mucosa is seen in inspection, based on concha nasalis inferior, smooth surface, that touches is flexible, caves in the mucosa that can make of probe pressures, remove probe after recess can calm down very soon.To the vasoconstrictor response sensitivity.
Hypertrophic rhinitis: having a stuffy nose is persistence, and rhinophonia is heavier, and hyposmia is obvious, and the nasal mucus amount is few and glutinous, is difficult for blowing out.Check that visible bronchia mucosal is kermesinus or pale asphyxia, concha nasalis hypertrophy hypertrophy, performance is uneven, and is nodal-like or Fructus Mori sample, and the poor flexibility of touching with the depression that is difficult for of probe pressures, removes that depression is difficult behind the probe calms down very soon.Insensitive to vasoconstrictor response.The Therapeutic Principle of primary disease recovers the nasal airflow function for eradicating the cause of disease, removes secretions.
The traditional Chinese medical science claims that primary disease is " stuffy nose ", mostly is evil stagnant, the caused by energy stagnation and blood stasis of the deficiency of the lung.Chronic rhinitis has intractable and recurrent characteristics, and common Western medicine is all cured the symptoms, not the disease, and is difficult to it is thoroughly eradicated.
Therefore, need a kind of Chinese medicine pill of new treatment chronic rhinitis with better treatment chronic rhinitis.
Summary of the invention
In view of this, the present invention is devoted to better to treat chronic rhinitis, has proposed a kind of Chinese medicine pill for the treatment of chronic rhinitis.
According to technical scheme of the present invention, provide a kind of Chinese medicine pill for the treatment of chronic rhinitis.This Chinese medicine pill comprises the Chinese medicinal components that following weight ratio is formed: 8~10 parts of Radix Bupleuri, 8~10 parts of Herba Menthaes, 8~10 parts of Fructus Viticises, 8~10 parts of Radix Saposhnikoviaes, 8~10 parts of Herba Schizonepetaes, 8~10 parts of Radix Scutellariae, 8~10 parts of Radix Platycodoniss, 8~10 parts of Rhizoma Chuanxiongs, 8~10 parts of the Radixs Angelicae Dahuricae, 8~10 parts of Fructus Aurantiis, 80~100 parts on Cornu Bovis seu Bubali, 4~5 parts of Herba Asaris, 4~5 parts of Radix Gentianaes, 12~15 parts of Flos Magnoliaes.
Its best component situation is: 10 parts of Radix Bupleuri, 10 parts of Herba Menthaes, 10 parts of Fructus Viticises, 10 parts of Radix Saposhnikoviaes, 10 parts of Herba Schizonepetaes, 10 parts of Radix Scutellariae, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Fructus Aurantiis, 100 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.
Use usage: the Chinese medicine of said components ratio is ground into smalls, making pellets by mixing medical powder with honey, the heavy 3.5g of every ball.Day obeys 2 times or 3 times, each 1 ball or 2 balls, and children's is cut down according to the circumstance, the careful clothes of anemia of pregnant woman.Perhaps, medicinal Oleum Sesami in the said components ratio boiled be ointment, be applied in the nostril outward.Every day twice, sooner or later respectively once.10 days is a course for the treatment of, and take effect a course for the treatment of, and can eradicate 3 courses for the treatment of.Food, Semen phaseoli radiati, green tea etc. avoid pungent food during the medication.
Among the present invention, Radix Bupleuri: evacuate and bring down a fever, soothing liver-QI, yang invigorating has calmness, blood pressure lowering, expansion bronchus, spasmolytic and antiinflammatory action.
Herba Menthae: suffering, lung, Liver Channel are returned in cold, and the wind heat of dispersing is arranged, clearing throat, rash detoxifcation, dispersing the stagnated live-QI to relieve the stagnation of QI and effect such as antipruritic.
Fructus Viticis: control the Taiyang channel headache, dizzy vexed, except dizzy order is dark, the medicine of the ailment said due to cold or exposure of loosing also.
Radix Saposhnikoviae: expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion.
Herba Schizonepetae: the diffusing wind that induces sweat, rash.
Radix Scutellariae: also claim Chimonanthus salicifolius S.Y.Hu., dark brown golden yellow, the clear pestilence of pathogenic fire purging has effects such as antibiotic, analgesic, blood pressure lowering.
Radix Platycodonis: effects such as eliminating phlegm and stopping cough, evacuation of pus are arranged.
Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping is used for pacifying nerve, positive wind syndrome of head headache.
The Radix Angelicae Dahuricae: expelling wind and cold, understand things pain-stopping, detumescence and apocenosis, dampness leukorrhagia stopping.
Fructus Aurantii: control that septum pectorale expectorant is let out, the trusted subordinate is depressed, two help the axil pain, and dyspepsia does not disappear, and effects such as pus and pain disappear.
Cornu Bovis seu Bubali: cooling blood for hemostasis, heat-clearing and toxic substances removing.
Herba Asari: dispel the wind, cold expelling, row water is had one's ideas straightened out; Control air-cooled headache, nasal sinusitis, toothache, phlegm retention cough with dyspnea, rheumatic arthralgia.
Radix Gentianae: the nature and flavor hardship, puckery, Great Cold, nontoxic; Cure mainly cold and heat between bone, frightened pathogenic factor gas.
Flos Magnoliae: cure mainly nasal sinusitis, nasal obstruction.
The present invention treats the Chinese medicine pill expelling wind and cold of chronic rhinitis, and reducing swelling and alleviating pain improves the internal medium of nose and repairs the nasal membrane tissue that pathological changes takes place.Be applicable to common rhinitis etc., life-time service has the elimination effect to the intractable chronic rhinitis.
Result through clinical 200 example uses, cure rate reaches 93.7%, and (recovery from illness: nasal airflow is good, secretions reduces, the nasal conchae hypertrophy situation is thoroughly improved, the headache situation that occurs together disappears), the improver reaches 4% (improver: more preceding ventilation has improvement and secretions to reduce, but does not see normal fully).
Clinical practice example of the present invention is as follows:
Example one, Zhang Gang, the man, 35 years old, people from Shizhong District, Zhangye suffered from surplus the chronic rhinitis 10 year, long-term nasal obstruction, watery nasal discharge, the concha nasalis enlargement, intermittent headache occurs together.Use Chinese medicine pill of the present invention, oral administration and externally used, take effect 1 course for the treatment of, and thoroughly eradicate 3 courses for the treatment of, and concha nasalis recovers original size, and not recurrence in 3 years.
Example two, Lin Li, the woman, 44 years old, Herba Kalimeridis people from city suffered from chronic rhinitis 7 years, during cold and hot season alternation, sneeze often, the situation aggravation does not have olfactory sensation fully when getting angry, and the nose ventilation is not smooth.Use Chinese medicine pill of the present invention, for oral administration 1 the course for the treatment of sx, removed symptom 2 courses for the treatment of, under doctor's suggestion, take the 3rd course for the treatment of, rhinitis is not recommitted so far.
Example three, Zhang Huankang, the man, 4 years old, people from Huangzhong, Xining, caught a cold from 2 years old chronic rhinitis, when outbreak, adopt intranasal to splash into vasoconstrictor usually, can improve ventilation and the drain of nasal cavity as 1% ephedrine etc., inflammation is disappeared, but but outbreak often.Use Chinese medicine pill of the present invention, 1 course for the treatment of for oral administration, nasal discharge obviously reduces, and checks to see that the congested situation of nasal mucosa is eased, use 3 courses for the treatment of after, symptom is thoroughly eliminated, and does not have recurrence so far.
Example four, Wang Haijun, the man, 45 years old, the office worker of Guinan statistics bureau suffered from chronic rhinitis 5 years.Because intranasal hamartoplasia, mucomembranous surface is uneven, and concha nasalis inferior is the Fructus Mori shape to be changed, and the middle nasal concha mucosa is polypoid and becomes, hypopnea, olfactory sensation completely without.Take 1 course for the treatment of of Chinese medicine pill of the present invention, breath state is eased, and after 2 courses for the treatment of, olfactory sensation part gradually recovers, and it is smooth that nasal mucosa begins to become, and after 3 courses for the treatment of, olfactory sensation recovers, and concha nasalis inferior restores to the original state, and the middle nasal concha polyp disappears.
Example five, Xue Liping, the woman, 31 years old, Xining Chengbei District people suffered from chronic rhinitis 10 years.Forehead pain is lain awake all night unbearably when serious, and it is obstructed to have a stuffy nose, and intracavity has the pus point, and purulent secretion is arranged, and once accepts puncture for treating, and effect is not ideal enough, often recurrence.After take 1 course for the treatment of of Chinese medicine pill of the present invention, nasal cavity purulence thing reduces, ventilation makes moderate progress.Again through the treatments of 2 courses for the treatment of, the rhinitis transference cure, its headache that occurs together does not occur yet, not recurrence in 2 years.
The invention has the beneficial effects as follows: the present invention adopts Chinese medicine preparation, and side effect is little, simultaneously, only can thoroughly be eradicated by taking medicine of certain course for the treatment of the intractable chronic rhinitis, and expense is relatively also low.
The specific embodiment
In order better to treat chronic rhinitis, the invention provides a kind of Chinese medicine pill for the treatment of chronic rhinitis.Next specify the Chinese medicine pill of this treatment chronic rhinitis in conjunction with the embodiments.
Embodiment one
Chinese medicine pill of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 8 parts of Radix Bupleuri, 8 parts of Herba Menthaes, 8 parts of Fructus Viticises, 8 parts of Radix Saposhnikoviaes, 8 parts of Herba Schizonepetaes, 8 parts of Radix Scutellariae, 8 parts of Radix Platycodoniss, 8 parts of Rhizoma Chuanxiongs, 8 parts of the Radixs Angelicae Dahuricae, 8 parts of Fructus Aurantiis, 100 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.The Chinese medicine of said components ratio is ground into smalls, making pellets by mixing medical powder with honey, the heavy 3.5g of every ball.
Embodiment two
Chinese medicine pill of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 10 parts of Radix Bupleuri, 10 parts of Herba Menthaes, 10 parts of Fructus Viticises, 10 parts of Radix Saposhnikoviaes, 10 parts of Herba Schizonepetaes, 10 parts of Radix Scutellariae, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Fructus Aurantiis, 80 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.The Chinese medicine of said components ratio is ground into smalls, making pellets by mixing medical powder with honey, the heavy 5g of every ball.
Embodiment three
Chinese medicine pill of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 9 parts of Radix Bupleuri, 9 parts of Herba Menthaes, 9 parts of Fructus Viticises, 9 parts of Radix Saposhnikoviaes, 10 parts of Herba Schizonepetaes, 10 parts of Radix Scutellariae, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Fructus Aurantiis, 100 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.The Chinese medicine of said components ratio is ground into smalls, making pellets by mixing medical powder with honey, the heavy 5g of every ball.
Embodiment four
Chinese medicine pill of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 10 parts of Radix Bupleuri, 10 parts of Herba Menthaes, 10 parts of Fructus Viticises, 10 parts of Radix Saposhnikoviaes, 10 parts of Herba Schizonepetaes, 10 parts of Radix Scutellariae, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Fructus Aurantiis, 100 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.The Chinese medicine of said components ratio is ground into smalls, making pellets by mixing medical powder with honey, the heavy 3.5g of every ball.
Embodiment five
Chinese medicine mixture of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 9 parts of Radix Bupleuri, 9 parts of Herba Menthaes, 9 parts of Fructus Viticises, 9 parts of Radix Saposhnikoviaes, 10 parts of Herba Schizonepetaes, 10 parts of Radix Scutellariae, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Fructus Aurantiis, 80 parts on Cornu Bovis seu Bubali, 4 parts of Herba Asaris, 4 parts of Radix Gentianaes, 12 parts of Flos Magnoliaes.The raw material of Chinese medicine of said components ratio is pulverized, be brewed into paste with Oleum Sesami and get final product, in order to external application.
Embodiment six
Chinese medicine mixture of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 8 parts of Radix Bupleuri, 8 parts of Herba Menthaes, 8 parts of Fructus Viticises, 8 parts of Radix Saposhnikoviaes, 8 parts of Herba Schizonepetaes, 8 parts of Radix Scutellariae, 8 parts of Radix Platycodoniss, 8 parts of Rhizoma Chuanxiongs, 8 parts of the Radixs Angelicae Dahuricae, 8 parts of Fructus Aurantiis, 100 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.The raw material of Chinese medicine of said components ratio is pulverized, be brewed into paste with Oleum Sesami and get final product, in order to external application.
More than specific descriptions of the present invention are intended to illustrate the implementation of specific embodiments can not be interpreted as it is limitation of the present invention.Those of ordinary skills can make various variants on the basis of the embodiment that describes in detail under instruction of the present invention, these variants all should be included within the design of the present invention.The present invention's scope required for protection is only limited by described claims.

Claims (2)

1. a Chinese medicine pill for the treatment of chronic rhinitis is characterized in that: comprise the Chinese medicinal components that following weight ratio is formed: 8~10 parts of Radix Bupleuri, 8~10 parts of Herba Menthaes, 8~10 parts of Fructus Viticises, 8~10 parts of Radix Saposhnikoviaes, 8~10 parts of Herba Schizonepetaes, 8~10 parts of Radix Scutellariae, 8~10 parts of Radix Platycodoniss, 8~10 parts of Rhizoma Chuanxiongs, 8~10 parts of the Radixs Angelicae Dahuricae, 8~10 parts of Fructus Aurantiis, 80~100 parts on Cornu Bovis seu Bubali, 4~5 parts of Herba Asaris, 4~5 parts of Radix Gentianaes, 12~15 parts of Flos Magnoliaes.
2. the Chinese medicine pill for the treatment of chronic rhinitis as claimed in claim 1 is characterized in that: comprise the Chinese medicinal components that following weight ratio is formed: 10 parts of Radix Bupleuri, 10 parts of Herba Menthaes, 10 parts of Fructus Viticises, 10 parts of Radix Saposhnikoviaes, 10 parts of Herba Schizonepetaes, 10 parts of Radix Scutellariae, 10 parts of Radix Platycodoniss, 10 parts of Rhizoma Chuanxiongs, 10 parts of the Radixs Angelicae Dahuricae, 10 parts of Fructus Aurantiis, 100 parts on Cornu Bovis seu Bubali, 5 parts of Herba Asaris, 5 parts of Radix Gentianaes, 15 parts of Flos Magnoliaes.
CN2012100402814A 2012-02-22 2012-02-22 Traditional Chinese medicine pill for treatment of chronic rhinitis Pending CN103285169A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100402814A CN103285169A (en) 2012-02-22 2012-02-22 Traditional Chinese medicine pill for treatment of chronic rhinitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100402814A CN103285169A (en) 2012-02-22 2012-02-22 Traditional Chinese medicine pill for treatment of chronic rhinitis

Publications (1)

Publication Number Publication Date
CN103285169A true CN103285169A (en) 2013-09-11

Family

ID=49087058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100402814A Pending CN103285169A (en) 2012-02-22 2012-02-22 Traditional Chinese medicine pill for treatment of chronic rhinitis

Country Status (1)

Country Link
CN (1) CN103285169A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189730A (en) * 2014-07-30 2014-12-10 严中明 Traditional Chinese medicine composition for treating rhinorrhea caused by heat stagnation in gallbladder
CN104491332A (en) * 2014-12-31 2015-04-08 秦富英 Rhinallergosis rhinitis cream

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189730A (en) * 2014-07-30 2014-12-10 严中明 Traditional Chinese medicine composition for treating rhinorrhea caused by heat stagnation in gallbladder
CN104491332A (en) * 2014-12-31 2015-04-08 秦富英 Rhinallergosis rhinitis cream

Similar Documents

Publication Publication Date Title
CN102793747A (en) Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis
CN103099948A (en) Pharmaceutical composition for treating pharyngitis and preparation method
CN103463416A (en) Traditional Chinese medicine preparation for treating rhinitis and pharyngitis
CN103356792B (en) Chinese medicine composition for treating chronic rhinitis
CN101979022A (en) Chinese medicinal mixture for treating chronic rhinitis
CN104352587A (en) Ointment for treating rhinitis
CN102451238B (en) Chinese medicinal preparation for treating rhinitis
CN101129636A (en) Medicine for treating nasal inflammation
CN103768429A (en) Traditional Chinese medicinal composition for treating acute and chronic pharyngitis and preparation method thereof
CN103230513B (en) A kind of Chinese drug-treated group mixture for the treatment of acute and chronic rhinitis and preparation method thereof
CN105012585A (en) Traditional Chinese medicine for treating rhinitis
CN101209322B (en) 'Chuierbaoting' powder
CN103285169A (en) Traditional Chinese medicine pill for treatment of chronic rhinitis
CN1320895C (en) Rhinitis treating Chinese medicine prepn
CN105055841A (en) Medicine for treating chronic pharyngitis and preparing method thereof
CN102258650B (en) External rhinitis paste
CN101670050B (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN103638360A (en) Chinese medicine powder for treating nasosinusitis
CN101112509B (en) Oral administration Chinese traditional medicine composition for treating chronic sinusitis
CN101095824A (en) Pharynx-cleaning detoxicating capsule
CN103110774B (en) Chinese herbal preparation for treating epistaxis and preparation method thereof
CN104857075A (en) Traditional Chinese medicinal composition for treating rhinitis, nasal polyp and sphagitis, and preparation method thereof
CN102697894B (en) Medicinal composition for treating nasal cavity inflammatory disease and preparation method thereof
CN115040613B (en) Traditional Chinese medicine composition for improving fever symptoms of viral influenza, application and preparation
CN102441033A (en) Chinese medicine magnolia flower powder for treating chronic rhinitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130911